Dr Michael Pustilnik, DC in Ault, CO - Medicare Chiropractic Provider

Dr Michael Pustilnik, DC is a medicare enrolled "Chiropractor" provider in Ault, Colorado. He went to Logan College Of Chiropractic and graduated in 1999 and has 25 years of diverse experience with area of expertise as Chiropractic. His current practice location is 120 N 2nd Ave, Ault, Colorado. You can reach out to his office (for appointments etc.) via phone at (970) 834-2888.

Dr Michael Pustilnik is licensed to practice in Colorado (license number 4753) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1609861335.

Contact Information

	Dr Michael Pustilnik, DC
	120 N 2nd Ave, Ault, CO 80610
	(970) 834-2888
	(970) 834-2775

Healthcare Provider's Profile

Full Name	Dr Michael Pustilnik
Gender	Male
Speciality	Chiropractic
Experience	25 Years
Location	120 N 2nd Ave, Ault, Colorado
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Michael Pustilnik attended and graduated from Logan College Of Chiropractic in 1999

NPI Data:

NPI Number: 1609861335
Provider Enumeration Date: 09/19/2005
Last Update Date: 09/29/2011

Medicare PECOS Information:

PECOS PAC ID: 9739111378
Enrollment ID: I20050906000179

Medical Identifiers

Medical identifiers for Dr Michael Pustilnik such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1609861335	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
111N00000X	Chiropractor	4753 (Colorado)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Michael Pustilnik is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Michael Pustilnik, DC Po Box 249, Ault, CO 80610-0249 Ph: (970) 834-2888	Dr Michael Pustilnik, DC 120 N 2nd Ave, Ault, CO 80610 Ph: (970) 834-2888

News Archive

Enrollment complete in Jennerex' Phase 1 trial of JX-594 IV administration for solid tumors

Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today announced that it has completed patient enrollment in a Phase 1 clinical trial evaluating the intravenous (IV) administration of JX-594, the company's lead product for the treatment of solid tumors. Jennerex expects to report the results from this trial at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in May 2010.

Health Canada approves Solta Medical's Thermage CPT, Fraxel re:store Dual systems

Solta Medical, Inc., the pioneer in fractional resurfacing and non-invasive skin tightening and a market leader in aesthetic skin treatments, today announced Health Canada approval of its Thermage CPT™ and Fraxel re:store® Dual systems. These products are now available to physicians in Canada. In the fall of 2009, the company received U.S. FDA clearance to market and sell both the Thermage CPT and Fraxel re:store Dual systems. Both systems are now available in over 100 countries worldwide.

Study seeks to understand medication management challenges for home care providers

Medically high-risk patients and communication breakdowns between providers contribute to the difficulty of medication management for older adults receiving home health care, finds a study led by researchers at NYU Rory Meyers College of Nursing.

Brain exhibits similar changes in both ADHD and emotional instability disorders

In both ADHD and emotional instability disorders (eg borderline and antisocial personality disorder as well as conduct disorder in children), the brain exhibits similar changes in overlapping areas, meaning that the two types of conditions should be seen as related and attention should be paid to both during diagnosis.

Spyryx receives award from Cystic Fibrosis Foundation to development therapeutic peptides for CF

Spyryx Biosciences, Inc., a privately-held biopharmaceutical company developing novel therapeutics for obstructive lung diseases, announced today it has received an award from Cystic Fibrosis Foundation Therapeutics, which will support development of Spyryx' therapeutic peptides for cystic fibrosis (CF).

Dr Michael Pustilnik, DC - Medicare Chiropractor in Ault, CO